MENU
ANAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
AnaptysBio (ANAB) Ownership - Who owns AnaptysBio?
AnaptysBio Inc is a clinical-stage biotechnology company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
10770 Wateridge Circle
Phone
+1 858 362-6295
Employees
117
Web
https://www.anaptysbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
569.53M
P/E Ratio
N/A
Total Cash
265.71M
Projected Growth
N/A
Total Debt
15.1M
Revenue
123.16M
Risk (Beta)
0.20
Dividend Yield
N/A
Total Cash/Share
9.50
Total Debt/Equity
N/A
Revenue/Share
4.15 USD as % of share price
Fundamentals
ANAB
Capitalization
570M
P/E Ratio
N/A
Risk (Beta)
0.20
Dividend Yield
N/A
Total Cash
266M
Total Cash/Share
9.50
Total Debt
15.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.15%
Revenue
123M
ROE
N/A
Book Value
-44.73M
P/B Ratio
17.30
Cash Flow
N/A
Earnings
-4.39
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
28K
Current Ratio
8.22
Current Revenue Per Employee
163698.53
Dividends Per Share - Security
N/A
EBITDA
-59.63M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-34.77
Shares Held By Institutions
1.04B
Shares Outstanding - Current
28M
Total Liabilities
380M
Total Volume MTD
N/A
Value
-1
Gain YTD
53.776
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ANAB showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a provider of therapeutic antibodies for inflammation and immuno-oncology
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
10770 Wateridge Circle
Phone
+1 858 362-6295
Employees
117
Web
https://www.anaptysbio.com